Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group
- PMID: 7050440
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group
Abstract
The Multiple Risk Factor Intervention Trial was a randomized primary prevention trial to test the effect of a multifactor intervention program on mortality from coronary heart disease (CHD) in 12,866 high-risk men aged 35 to 57 years. Men were randomly assigned either to a special intervention (SI) program consisting of stepped-care treatment for hypertension, counseling for cigarette smoking, and dietary advice for lowering blood cholesterol levels, or to their usual sources of health care in the community (UC). Over an average follow-up period of seven years, risk factor levels declined in both groups, but to a greater degree for the SI men. Mortality from CHD was 17.9 deaths per 1,000 in the SI group and 19.3 per 1,000 in the UC group, a statistically nonsignificant difference of 7.1% (90% confidence interval, -15% to 25). Total mortality rates were 41.2 per 1,000 (SI) and 40.4 per 1,000 (UC). Three possible explanations for these findings are considered: (1) the overall intervention program, under these circumstances, does not affect CHD mortality; (2) the intervention used does affect CHD mortality, but the benefit was not observed in this trial of seven years' average duration, with lower-than-expected mortality and with considerable risk factor change in the UC group; and (3) measures to reduce cigarette smoking and to lower blood cholesterol levels may have reduced CHD mortality within subgroups of the SI cohort, with a possibly unfavorable response to antihypertensive drug therapy in certain but not all hypertensive subjects. This last possibility was considered most likely, needs further investigation, and lends support to some preventive measures while requiring reassessment of others.
Similar articles
-
Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.Prev Med. 1985 May;14(3):293-311. doi: 10.1016/0091-7435(85)90058-1. Prev Med. 1985. PMID: 3903734 Clinical Trial.
-
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.Circulation. 1990 Nov;82(5):1616-28. doi: 10.1161/01.cir.82.5.1616. Circulation. 1990. PMID: 2225366 Clinical Trial.
-
Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.Am J Cardiol. 1986 Jul 1;58(1):1-13. doi: 10.1016/0002-9149(86)90232-8. Am J Cardiol. 1986. PMID: 2873741 Clinical Trial.
-
Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.Clin Invest Med. 1987 Nov;10(6):606-15. Clin Invest Med. 1987. PMID: 3326700 Review.
-
Risk factors for coronary heart disease in women.Cardiol Clin. 1998 Feb;16(1):1-8. doi: 10.1016/s0733-8651(05)70378-7. Cardiol Clin. 1998. PMID: 9507775 Review.
Cited by
-
Use of Coronary Computed Tomography Angiography to Screen Hospital Employees with Cardiovascular Risk Factors.Int J Environ Res Public Health. 2021 May 20;18(10):5462. doi: 10.3390/ijerph18105462. Int J Environ Res Public Health. 2021. PMID: 34065262 Free PMC article.
-
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).Circulation. 2013 Apr 16;127(15):1630-5. doi: 10.1161/CIRCULATIONAHA.112.000779. Circulation. 2013. PMID: 23588961 Free PMC article. No abstract available.
-
Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.Eur J Clin Pharmacol. 1986;30(5):535-40. doi: 10.1007/BF00542411. Eur J Clin Pharmacol. 1986. PMID: 3758141 Clinical Trial.
-
Newer beta blockers and the treatment of hypertension.Cardiovasc Drugs Ther. 1991 Jun;5(3):577-87. doi: 10.1007/BF03029727. Cardiovasc Drugs Ther. 1991. PMID: 1678961 Review.
-
Do different hemodynamic effects of antihypertensive drugs translate into different safety profiles?Eur J Clin Pharmacol. 1990;38 Suppl 2:S134-8. doi: 10.1007/BF01409483. Eur J Clin Pharmacol. 1990. PMID: 2200692 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical